Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	129.94	103.15	-44.86
Graham Fair Price	1.12	2275.21	2249.96
PEG	-2087.85	-6.24	-0.29
Price/Book	-7.91	0.89	0.97
Price/Cash Flow	inf	0.00	157.77
Prices/Earnings	10.00	-14.30	-15.88
Price/Sales	-19.03	1.30	1.61
Price/FCF	inf	0.00	157.77
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	108.37	0.05	0.02
Operating Margin	-65.04	< 0.005	-0.02
ROA	-1.86	< 0.005	< 0.005
ROE	-0.02	-0.02	-2.32
ROIC	< 0.005	0.01	39.18
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.18	0.57	-68.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-2.63	1.40	-46.90
EPS QOQ	-0.56	-0.02	95.89
FCF QOQ	0.04	-1.00	2387.50
Revenue QOQ	< 0.005	0.14	5421.90
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.88	2.57	-62.67
Days Sales Outstanding (DSO)	213.49	202.70	-5.05
Inventory Turnover	13.09	35.06	167.91
Debt/Capitalization	0.14	0.16	15.27
Quick Ratio	1.50	1.47	-1.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	3847.93	3846.72	-0.03
Cash	1517.34	996.80	-34.31
Capex	0.00	0.00	0.00
Free Cash Flow	23.55	0.00	inf
Revenue	2313.98	2630.81	13.69
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.64	1.63	-0.91
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	14.20	-8.46	-40.41
Naive Interpretation	Member

06 - Financial Health · Weak

Rating